Melanoma live: Making patient-focused therapy decisions

Complexity of intra- and inter-pathway loops in colon cancer and melanoma: Implications for targeted therapies

Combining immunological and targeted agents in melanoma

Advances in diagnostic devices in melanoma screening

PD-1 targeting immunotherapy MK-3475 has high, long-lasting activity against metastatic melanoma

Ipilimumab and nivolumab achieves long-term survival in advanced melanoma

Adjuvant ipilimumab improves recurrence-free survival in high-risk stage III melanoma

Comment: Adjuvant ipilimumab in high-risk melanoma

Comment: PD-1 targeting MK-3475 gives long-term responses in melanoma

Comment: Immunotherapy combo increases median survival in advanced melanoma

Success for ipilimumab and nivolumab combo in advanced melanoma

T-VEC injections into melanoma lesions show significant response rate